These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

119 related items for PubMed ID: 1279324

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42. Terminal deoxynucleotidyl transferase expression in acute myelogenous leukemia and myelodysplasia as determined by flow cytometry.
    Huh YO, Smith TL, Collins P, Bueso-Ramos C, Albitar M, Kantarjian HM, Pierce SA, Freireich EJ.
    Leuk Lymphoma; 2000 Apr; 37(3-4):319-31. PubMed ID: 10752983
    [Abstract] [Full Text] [Related]

  • 43. Clinical significance of CD95, Bcl-2 and Bax expression and CD95 function in adult de novo acute myeloid leukemia in context of P-glycoprotein function, maturation stage, and cytogenetics.
    Wuchter C, Karawajew L, Ruppert V, Büchner T, Schoch C, Haferlach T, Ratei R, Dörken B, Ludwig WD.
    Leukemia; 1999 Dec; 13(12):1943-53. PubMed ID: 10602414
    [Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45. Prognostic significance of terminal transferase and adenosine deaminase in acute and chronic myeloid leukemia.
    Bertazzoni U, Brusamolino E, Isernia P, Scovassi AI, Torsello S, Lazzarino M, Bernasconi C.
    Blood; 1982 Sep; 60(3):685-92. PubMed ID: 7049266
    [Abstract] [Full Text] [Related]

  • 46. Analysis of treatment failure in patients with minimally differentiated acute myeloid leukemia (AML-M0).
    Stasi R, Del Poeta G, Venditti A, Masi M, Stipa E, Dentamaro T, Cox C, Dallapiccola B, Papa G.
    Blood; 1994 Mar 15; 83(6):1619-25. PubMed ID: 8123853
    [Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49. Prognostic importance of immunophenotyping in adults with acute myelocytic leukaemia: the significance of the stem-cell glycoprotein CD34 (My10).
    Geller RB, Zahurak M, Hurwitz CA, Burke PJ, Karp JE, Piantadosi S, Civin CI.
    Br J Haematol; 1990 Nov 15; 76(3):340-7. PubMed ID: 1702006
    [Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51. Prognostic significance of terminal deoxynucleotidyl transferase activity in acute nonlymphoblastic leukemia.
    Benedetto P, Mertelsmann R, Szatrowski TH, Andreeff M, Gee T, Arlin Z, Kempin S, Clarkson B.
    J Clin Oncol; 1986 Apr 15; 4(4):489-95. PubMed ID: 3958762
    [Abstract] [Full Text] [Related]

  • 52. Biologic and clinical significance of CD7 expression in acute myeloid leukemia.
    Saxena A, Sheridan DP, Card RT, McPeek AM, Mewdell CC, Skinnider LF.
    Am J Hematol; 1998 Aug 15; 58(4):278-84. PubMed ID: 9692390
    [Abstract] [Full Text] [Related]

  • 53. Prognostic implications of TdT expression in acute myeloid leukemia with an intermediate-risk karyotype.
    Saburi M, Ogata M, Satou T, Soga Y, Itani K, Kohno K, Kondo Y, Nakayama T.
    Int J Hematol; 2020 Jul 15; 112(1):17-23. PubMed ID: 32253665
    [Abstract] [Full Text] [Related]

  • 54. Minimally differentiated acute myeloid leukemia in Taiwan: predominantly occurs in children less than 3 years and adults between 51 and 70 years.
    Huang SY, Tang JL, Jou ST, Tsay W, Hu CH, Lin DT, Lin KS, Lin KS, Wang CH, Chen YC, Shen MC, Tien HF.
    Leukemia; 1999 Oct 15; 13(10):1506-12. PubMed ID: 10516750
    [Abstract] [Full Text] [Related]

  • 55. Prognostic significance of surface marker expression on blasts of patients with de novo acute myeloblastic leukemia.
    Schwarzinger I, Valent P, Köller U, Marosi C, Schneider B, Haas O, Knapp W, Lechner K, Bettelheim P.
    J Clin Oncol; 1990 Mar 15; 8(3):423-30. PubMed ID: 2307987
    [Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57. [Acute nonmyeloid leukemia in adults. Study of membrane antigens and terminal transferase. Diagnostic and prognostic value].
    Ifrah N, Perrot JY, Marie JP, Rio B, Julien C, Cadiou M, Boucheix C, Zittoun R.
    Presse Med; 1985 Jan 26; 14(3):137-41. PubMed ID: 3156336
    [Abstract] [Full Text] [Related]

  • 58. Surface marker expression in adult acute myeloid leukaemia: correlations with initial characteristics, morphology and response to therapy.
    Campos L, Guyotat D, Archimbaud E, Devaux Y, Treille D, Larese A, Maupas J, Gentilhomme O, Ehrsam A, Fiere D.
    Br J Haematol; 1989 Jun 26; 72(2):161-6. PubMed ID: 2757962
    [Abstract] [Full Text] [Related]

  • 59. High bcl-2 expression in acute myeloid leukemia cells correlates with CD34 positivity and complete remission rate.
    Lauria F, Raspadori D, Rondelli D, Ventura MA, Fiacchini M, Visani G, Forconi F, Tura S.
    Leukemia; 1997 Dec 26; 11(12):2075-8. PubMed ID: 9447823
    [Abstract] [Full Text] [Related]

  • 60. Prognostic significance of terminal transferase activity and glucocorticoid receptor levels in acute myeloid leukemia.
    Skoog L, Ost A, Biberfeld P, Christensson B, Hast R, Lagerlöf B, Nordenskjöld B, Reizenstein P.
    Br J Cancer; 1984 Oct 26; 50(4):443-9. PubMed ID: 6593093
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.